SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (9894)10/21/1997 11:20:00 AM
From: Henry Niman  Respond to of 32384
 
chirodoc, There was some big boy action at the open. LGND is still in the middle of their road show (Oppenheimer next week, Robertson Stephens in December, and H&Q in January) and I expect much more big boy action (as well as some new coverage by major brokers).



To: chirodoc who wrote (9894)10/21/1997 11:29:00 AM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
Speaking of LLY, its new SERM, Evista (Raloxifene) was the June "molecule of the month" (Targretin was the molecule of the month last December):

prous.es


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News